MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.

Tian S, Zhang M, Chen X, Liu Y, Lou G

DOI: 10.18632/oncotarget.13526
Published: 2016 Dec 27
Container: Oncotarget
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.13526,
  title = {MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.},
  author = {Tian S and Zhang M and Chen X and Liu Y and Lou G},
  year = {2016},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.13526},
  url = {https://doi.org/10.18632/oncotarget.13526}
}

RIS

TY  - JOUR
TI  - MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.
AU  - Tian S
AU  - Zhang M
AU  - Chen X
AU  - Liu Y
AU  - Lou G
PY  - 2016
JO  - Oncotarget
DO  - 10.18632/oncotarget.13526
UR  - https://doi.org/10.18632/oncotarget.13526
ER  -

APA

S, T., M, Z., X, C., Y, L., & G, L. (2016). MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.. Oncotarget. https://doi.org/10.18632/oncotarget.13526

Source records

pubmed · retrieved 2026-09-25T02:31:23.404Z